help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kluve-Beckerman, B.
Right arrow Articles by Benson, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kluve-Beckerman, B.
Right arrow Articles by Benson, M. D.
(American Journal of Pathology. 1999;155:123-133.)
© 1999 American Society for Investigative Pathology

Regular Articles

A Cell Culture System for the Study of Amyloid Pathogenesis

Amyloid Formation by Peritoneal Macrophages Cultured withRecombinant Serum Amyloid A

Barbara Kluve-Beckerman*, Juris J. Liepnieks*, Lishan Wang* and Merrill D. Benson*{dagger}

From the Department of Medical and Molecular Genetics,*
Indiana University School of Medicine, and Richard L. Roudebush Veterans Affairs Medical Center,{dagger}
Indianapolis, Indiana

A murine macrophage culture system that is both easy to employ and amenable to manipulation has been developed to study the cellular processes involved in AA amyloid formation. Amyloid deposition, as identified by Congo red-positive, green birefringent material, is achieved by providing cultures with recombinant serum amyloid A2 (rSAA2), a defined, readily produced, and highly amyloidogenic protein. In contrast to fibril formation, which can occur in vitro with very high concentrations of SAA and low pH, amyloid deposition in culture is dependent on metabolically active macrophages maintained in neutral pH medium containing rSAA2 at a concentration typical of that seen in acute phase serum. Although amyloid-enhancing factor is not required, its addition to culture medium results in larger and more numerous amyloid deposits. Amyloid formation in culture is accompanied by C-terminal processing of SAA and the generation of an 8.5-kd fragment analogous to amyloid A protein produced in vivo. Consistent with the possibility that impaired catabolism of SAA plays a role in AA amyloid pathogenesis, treatment of macrophages with pepstatin, an aspartic protease inhibitor, results in increased amyloid deposition. Finally, the amyloidogenicity exhibited by SAA proteins in macrophage cultures parallels that seen in vivo, eg, SAA2 is highly amyloidogenic, whereas CE/J SAA is nonamyloidogenic. The macrophage culture model presented here offers a new approach to the study of AA amyloid pathogenesis.




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
J. C. H. van der Hilst, B. Kluve-Beckerman, E. J. Bodar, J. W. M. van der Meer, J. P. H. Drenth, and A. Simon
Lovastatin inhibits formation of AA amyloid
J. Leukoc. Biol., May 1, 2008; 83(5): 1295 - 1299.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. J. Morten, W. S. Gosal, S. E. Radford, and E. W. Hewitt
Investigation into the Role of Macrophages in the Formation and Degradation of beta2-Microglobulin Amyloid Fibrils
J. Biol. Chem., October 5, 2007; 282(40): 29691 - 29700.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. P. Gellermann, T. R. Appel, A. Tannert, A. Radestock, P. Hortschansky, V. Schroeckh, C. Leisner, T. Lutkepohl, S. Shtrasburg, C. Rocken, et al.
Raft lipids as common components of human extracellular amyloid fibrils
PNAS, May 3, 2005; 102(18): 6297 - 6302.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Kisilevsky, W. A. Szarek, J. B. Ancsin, E. Elimova, S. Marone, S. Bhat, and A. Berkin
Inhibition of Amyloid A Amyloidogenesis in Vivo and in Tissue Culture by 4-Deoxy Analogues of Peracetylated 2-Acetamido-2-Deoxy-{alpha}- and {beta}-D-Glucose: Implications for the Treatment of Various Amyloidoses
Am. J. Pathol., June 1, 2004; 164(6): 2127 - 2137.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.